Keyword: moderna
-
Dr. Joseph Ladapo, Florida’s top health official, co-authored the preprint paper.. Florida adults who received Pfizer’s COVID-19 vaccine were more likely to die following vaccination than Moderna COVID-19 recipients, according to a new preprint study that was co-authored by Florida’s top health official. Dr. Joseph Ladapo, Florida’s surgeon general, and other researchers identified nearly 9.2 million Florida adults not living in institutions who received at least two doses of the Pfizer or Moderna vaccine less than six weeks apart between Dec. 18, 2020, and Aug. 31, 2021. They narrowed the group to nearly 1.5 million, half who received Pfizer’s vaccine...
-
Despite multiple Freedom of Information Act (FOIA) requests seeking clarity on DNA contamination and plasmid DNA in Pfizer and Moderna’s COVID-19 vaccines, the official full genetic sequence of the plasmid DNA backbone—and the results of safety studies evaluating its risks—remain undisclosed. This new FOIA request, prompted by Dr. Richard Bartlett, aims to address these gaps and demand accountability. There is a proposed FOIA at the bottom of this article. Background: What We Already Know Several FOIA requests have previously sought information regarding DNA contamination in mRNA vaccines. For example: MHRA FOIA Response: The UK’s Medicines and Healthcare Products Regulatory Agency...
-
More empathy—and investment—is needed to address vaccine-related injuries, says Harvard T.H. Chan School of Public Health’s Kizzmekia Corbett-Helaire. Corbett-Helaire, assistant professor of immunology and infectious diseases, was one of the developers of the COVID-19 vaccine. She also talked about her June 11 opinion piece in STAT, in which she wrote that she believes more empathy is needed for people who report experiencing long-term side effects from the COVID-19 vaccine. “People who speak out about how they feel after getting a vaccine should not be dismissed or assumed to be anti-vaxxers,” she wrote. “For starters, they deserve empathy from their doctors...
-
Recent studies have illuminated the emergence of vaccine-induced acute pancreatitis, notably associated with COVID-19 vaccinations, presenting diverse mechanisms ranging from direct viral-mediated injury to autoimmune reactions. Understanding this link is pivotal for public health, yet challenges persist in identifying and managing cases post-vaccination.
-
A North Carolina mother and her son can sue a public school system and a doctors' group for allegedly giving the boy a COVID-19 vaccine without consent, the state Supreme Court ruled. Smith was vaccinated in August 2021 at age 14 despite his opposition at a testing and vaccination clinic at a Guilford County high school, according to the family's lawsuit. The teenager went to the clinic to be tested for COVID-19 after several cases among his school's football team, the lawsuit says. He did not anticipate that the clinic would also be administering vaccines. He told staff at the...
-
Friday marked the worst day of the year for the stock market as the Dow plummeted by 748.63 points, and pharmaceutical companies like Pfizer and Moderna stocks saw a significant rise. The surges come amid reports from researchers at the Wuhan Institute of Virology identifying a potentially deadlier strain of coronavirus known as HKU5-CoV-2, which the media is now parroting. COVID-19 originated in a lab in Wuhan, which the media have told us for years was untrue. The research, published Tuesday in the scientific journal Cell, began to spark concerns, drawing eerie parallels to the early days of the COVID-19...
-
Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine, Spikevax, said it expects revenue to range between $1.5 billion and $2.5 billion in 2025, compared to as much as $3.1 billion in 2024 and $19 billion during the peak of the pandemic. Why It Matters Moderna's revenue and stock price have steadily declined since global demand for COVID-19 vaccines has dwindled. During 2020 and 2021, the company generated massive revenues, fueled by its breakthrough mRNA technology. However, as...
-
* Pork producers in America have been administering mRNA-based gene therapy to pigs secretly, contaminating pork with self-assembling nanoparticles. * Harrisvaccines pioneered RNA-based livestock vaccines, acquired by Merck Animal Health in 2016, leading to the prevalence of unregulated gene therapy in the livestock sector. * Merck introduced Sequivity, a swine vaccine platform in collaboration with Moderna, without safety testing, raising concerns about consumer health risks. * Companies plan to expand mRNA “vaccines” to avian influenza, cows, and cattle, prompting the need for transparent labeling and stringent regulations to protect public health. * Consumers are advised to avoid pork products possibly...
-
If the aftermath of the first widespread mRNA vaccine was not enough to deter the public, the government and the Centers for Disease Control and Prevention (CDC) partnered with Moderna to create a new DNA-altering vaccination for the bird flu. And here we go again – Moderna said that their most recent vaccine is specifically for this variant (2.3.4.4b) of the flu, which has not spread from person-to-person contact. The Science Translational Medicine published Moderna’s study of the vaccine in which they exposed ferrets to the virus. Moderna won a $176 million federal funding package back in JULY to develop...
-
The outgoing Biden Administration has quietly extended a pandemic-era measure that protects Covid vaccine makers from being sued for injuries or deaths. Officials at the Health and Human Services (HHS) say it's necessary because there is still 'a credible risk' the pandemic spirals out of control in the next four years, even though Covid deaths and hospital admissions are at historic lows. The Public Readiness and Emergency Preparedness (PREP) Act was initially enacted in 2020, in part to encourage vaccine manufacturers to speed up their research of Covid vaccines without fear of being held legally responsible for things like side...
-
Moderna Inc.’s cost-reduction plans, pipeline cuts and reined-in financial guidance, unveiled Thursday, triggered a wave of downgrades as analysts focused on longer timelines to launch some products and questioned when the company will return to profitability.One key concern: The company’s full-year 2025 revenue guidance, issued Thursday, is nearly 8% lower, at the midpoint, than its full-year 2024 guidance — which was recently trimmed back. The 2025 forecast, on the heels of the 2024 guidance cut issued when Moderna reported second-quarter earnings, “is likely making investors lose confidence” and battering the stock, Evercore ISI analyst Cory Kasimov said in a research...
-
A peer-reviewed study reveals the existence of self-assembling nanoparticles within mRNA COVID-19 vaccines, raising new concerns over their potential impact.
-
Attorney Tom Renz has issued a stark warning about the FDA's decision to grant Emergency Use Authorization (EUA) to bird flu mRNA vaccines. Looking ahead, he says, “So what I would expect now is when Disease X rolls out, when the bird flu is something that they're gonna claim has made some sort of a dent in the human population, they're gonna try and push the bird flu vaccines in the same way that they pushed the COVID vaccines.” Renz cited a study showing gain-of-function research on bird flu in the United States before painting a chilling picture of the...
-
Shares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and 9.3%, respectively, through Thursday trading, according to data from S&P Global Market Intelligence. While these three stocks gained notoriety back in 2020 during the COVID-19 pandemic, it appears this week's detection of avian bird flu in a second U.S. citizen and the first-ever detection of avian flu in a human in Australia are spurring fears of an outbreak and thus a possible boon for companies that can quickly produce a bird flu vaccine. Bird flu detected in Michigan...
-
University of Colorado confirms graphene oxide is in dental anesthetics. - Karen Kingston.. Dr Lundstrom, a family dentist, who formerly had contacted me to provide Darkfield Microscopy testing on dental anesthetics, was able to get analysis done at the University of Boulder Colorado - and they confirmed Graphene. He has been posting the results of his endeavors to get answers on his website. Dr McKernan also did analysis, as did Clifford Carnicom and myself. You can find these results here: Dental Anesthetics analysis Dr Lundstrom They explain: We began the process of getting answers on the safety of dental anesthetic...
-
Moderna’s stock price plunged more than 20% in Thursday morning trading after the company lowered its 2024 revenue guidance due to weak demand for its coronavirus vaccine in the second quarter. The vaccine producer netted $241 million in revenue in Q2, which aligned with analyst expectations. However, it was a significant drop from the $344 million generated during the prior year period. Moderna said the decline was due to decreased demand for its COVID-19 vaccine. The vaccine generated sales of $184 million in Q2, a 37% decrease from the same period last year, but was higher than Jefferies’ estimate of...
-
Major Study of 9 Million Confirms Covid Shots Cause VAIDS An explosive new study, which analyzed the data of nine million people, has sent shockwaves through the scientific community after proving that Covid mRNA shots are responsible for the global surge in cases of AIDS-like vaccine-acquired immunodeficiency syndrome (VAIDS). The peer-reviewed study was conducted by a team of world-renowned South Korean researchers, led by Professor Solam Lee at Yonsei University Wonju College of Medicine’s Department of Dermatology.The primary cohort study analyzed official government data from the National Health Insurance Service (NHIS) and Korea Disease Control and Prevention Agency (KDCA) databases....
-
The United States government will pay vaccine manufacturer Moderna $176 million to develop a new mRNA vaccine to treat bird flu. The U.S. Department of Health and Human Services will pay Moderna $176 million for a vaccine containing the same mRNA technology as the company’s COVID-19 vaccine. ... Moderna will launch trials to test the safety and effectiveness of a vaccine that could be used to scale up a response to a bird flu pandemic if needed.
-
Let’s delve into the allegations against Justice Helen Rofe and the court case related to unapproved GMOs in Pfizer and Moderna’s mRNA Covid-19 vaccines: Justice Helen Rofe Allegations: A complaint filed with the Federal Court Chief Justice Debra Mortimer alleges that Justice Helen Rofe concealed her connections to Pfizer and the pharmaceutical industry before dismissing a case, to Pfizer’s advantage. Justice Rofe had prior affiliations with Pfizer, both directly and indirectly, during her time at the Bar1. Additionally, she has substantial associations with the pharmaceutical and scientific research industry, including her family’s involvement in the Grimwade family pharmaceutical fortune and...
-
Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. Moderna, Pfizer and Novavax have said that combination shots will simplify how people can protect themselves against respiratory viruses that typically surge around the same time of the year. The added convenience is critical as fewer Americans roll up their sleeves to get vaccinated against Covid.
|
|
|